首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1490049

閱讀障礙治療市場：按類型、按藥物類別、按分銷管道、按地區

Dyslexia Treatment Market, By Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2024年05月22日 | 出版商:

Coherent Market Insights | 英文 174 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球閱讀障礙治療市場規模估計為75.9億美元，2031年將達117.4億美元，2024年至2031年年複合成長率為6.4%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	75.9億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測2024-2031年年複合成長率：	6.40%	2031年價值預測	117.4億美元

圖：2024年誦讀困難治療市場佔有率（%），依地區分類

閱讀障礙是一種損害閱讀和寫作能力的學習障礙。它是一種具有很強遺傳成分的神經發育障礙。閱讀障礙有許多原因，包括語音處理、快速命名、工作記憶和處理速度的障礙。誦讀困難症患者在準確、流利的單字辨識方面持續存在困難，且拼字和解碼能力較差。全球約有 10%至 15%的人患有閱讀障礙。透過及時診斷和適當的治療和干涉，患有閱讀障礙的人可以學習策略，在閱讀、寫作和拼字方面更加成功。全球閱讀障礙治療市場提供評估和治療方案，幫助閱讀障礙患者提高識字能力並控制症狀。

市場動態：

全球閱讀障礙治療市場的成長是由於人們對閱讀障礙的認知不斷提高以及對其原因和管理方法的研究不斷增加而推動的。研究表明，美國有超過4000萬人存在一定程度的閱讀障礙，但只有10%的人接受了適當的干涉服務。缺乏接受閱讀障礙治療培訓的臨床醫生和教師可能會阻礙市場成長。此外，高昂的治療和教育費用也是普及的障礙。然而，早期診斷、行動應用程式和提高技能的嚴肅遊戲的先進技術的開拓可以為市場成長提供機會。目的是更佳了解閱讀障礙的遺傳學和神經生物學的大規模流行病學研究的投資可能會改善治療結果。

本研究的主要特點

本報告對全球閱讀障礙治療市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
根據公司亮點、產品系列、主要亮點，實績和策略等參數，提供全球誦讀困難治療市場主要企業的概況。
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球閱讀障礙治療市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球閱讀障礙治療市場的各種策略矩陣來促進他們的決策。

公司簡介
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Jubilant Pharma Limited
- GSK plc
- Eli Lilly and Company
- Otsuka Holdings Co., Ltd.
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals LP
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin

第10章分析師觀點

Wheel of Fortune
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7002

Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 7.59 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.40%	2031 Value Projection:	US$ 11.74 Bn

Figure. Dyslexia Treatment Market Share (%), By Region, 2024

Dyslexia is a learning disorder that impairs a person's ability to read and write. It is a neurodevelopmental disorder with a strong genetic component. There are multiple causes that contribute to dyslexia including difficulties with phonological processing, rapid naming, working memory and processing speed. It is a persistent difficulty in accurate and fluent word recognition and poor spelling and decoding abilities. Dyslexia affects approximately 10% to 15% of people worldwide. With timely diagnosis and appropriate treatment and intervention, people with dyslexia can learn strategies to read, write and spell much more successfully. Global dyslexia treatment market provides evaluation and treatment options to help dyslexic individuals achieve literacy skills and manage the symptoms.

Market Dynamics:

Global dyslexia treatment market growth is driven by growing awareness about dyslexia and increasing research on its causes and management approaches. According to studies, over 40 million people in the U.S. have some degree of dyslexia, however, only 10% receive appropriate intervention services. The shortage of trained clinicians and teachers for dyslexia treatment can hamper the market growth. High costs of therapies and education programs can also limit adoption. However, the development of advanced technologies for early diagnosis, mobile apps and serious games for skill building can provide opportunities for the market growth. Investments in large epidemiological studies that aim to better understand the genetics and neurobiology of dyslexia can improve treatment outcomes.

Key Features of the Study:

This report provides an in-depth analysis of the global dyslexia treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dyslexia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli Lilly and Company, Otsuka Holdings Co., Ltd., Apotex Corporation, Purdue Pharma, Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd., Wallace Pharmaceuticals Ltd., The Himmel Group, Astrazeneca, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Lupin
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global dyslexia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dyslexia treatment market

Detailed Segmentation-

By Type:
- Phonological Dyslexia
- Surface Dyslexia
- Double Deficit Dyslexia
- Others
By Drug Class:
- Antihistamines
- Central Nervous Stimulant
- Selective Norepinephrine Reuptake Inhibitors
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Jubilant Pharma Limited
- GSK plc
- Eli Lilly and Company
- Otsuka Holdings Co., Ltd.
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals L.P.
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Epidemiology
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Dyslexia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Dyslexia Treatment Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Phonological Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Surface Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Double Deficit Dyslexia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Dyslexia Treatment Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Antihistamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Central Nervous Stimulant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Selective Norepinephrine Reuptake Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Dyslexia Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Dyslexia Treatment Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Pfizer, Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant Pharma Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Otsuka Holdings Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Apotex Corporation
- Purdue Pharma
- Rhodes Pharmaceuticals L.P.
- Cian Healthcare Pvt. Ltd.
- Wallace Pharmaceuticals Ltd.
- The Himmel Group
- Astrazeneca
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Lupin